Nanotherapeutics for autoimmunity becomes mainstream.

Clin Immunol

Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA, USA. Electronic address:

Published: September 2015

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554816PMC
http://dx.doi.org/10.1016/j.clim.2015.07.006DOI Listing

Publication Analysis

Top Keywords

nanotherapeutics autoimmunity
4
autoimmunity mainstream
4
nanotherapeutics
1
mainstream
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!